STAN119i-192C1
** The karyotype for this cell line may contain a non-clonal finding known to be recurrent in pluripotent stem cells. Please see the karyotype report in the currently distributing lot(s) ``Product Information & Testing`` PDF(s) linked below for more information.An additional clone from this iPS cell line (STAN120i-192C2) is available from WiCell.
| Cell Line Alias | ISMMS 192i C1 |
| Cell Type | Human iPS |
| Disease | None reported |
| Sex | Male |
| Age at Collection | 64 Years |
| Ethnicity | Asian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Sendai Virus (Oct4, Klf4, Sox2, Myc) |
| Tissue Origin | Blood |
| Provider | Stanford University - Dr. Thomas Quertermous |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Insulin resistance syndrome (Dr. Thomas Quertermous, Stanford University) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB44249 | mTeSR1/Matrigel | 14 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
